Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Temporary Equity and Common Stockholders' Equity (Deficit)

v3.23.1
Consolidated Statements of Temporary Equity and Common Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Series A Preferred Stock [Member]
Preferred Stock [Member]
Series B Preferred Stock [Member]
Preferred Stock [Member]
Series C Preferred Stock [Member]
Preferred Stock [Member]
Temporary equity [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 12,356 $ 16,651 $ 29,007 $ 1,514 $ (37,954) $ (36,440)
Beginning balance, shares at Dec. 31, 2020 4,612,000 3,489,000   519,000        
Stock-based compensation 1,298 1,298
Exercise of stock options 41 $ 41
Exercise of stock options, shares         1,000       7,419
Foreign currency translation adjustment   (74) $ (74)
Net loss (40,859) (40,859)
Issuance of Series C Convertible Preferred shares, net of issuance costs of $214 $ 1,786 1,786
Issuance of Series C Convertible Preferred shares, net of issuance costs of $214, shares     567,000            
Issuance of Common Stock for acquisition consideration 59,920 59,920
Issuance of Common Stock for acquisition consideration, shares         2,201,000        
Issuance of Incremental shares to StemoniX shareholders upon Merger
Issuance of incremental shares to StemoniX shareholders upon Merger, shares         161,000        
Conversion of Preferred Stock to Common Stock upon Merger $ (12,356) $ (16,651) $ (1,786) (30,793) $ 1 30,792 30,793
Conversion of Preferred Stock to Common Stock upon Merger, shares (4,612,000) (3,489,000) (567,000)   2,239,000        
Conversion of 2020 Notes to Common Stock upon Merger 16,190 16,190
Conversion of 2020 Notes to Common Stock upon Merger, shares         668,000        
Preferred stock warrant settled for Common Stock upon Merger
Preferred stock warrant settled for Common Stock upon Merger, shares         9,000        
Warrant liability reclassified to equity upon Merger 421 421
Ending balance, value at Dec. 31, 2021 $ 1 110,176 (78,813) (74) 31,290
Ending balance, shares at Dec. 31, 2021 5,798,000        
Stock-based compensation 1,455 1,455
Exercise of stock options         4 $ 4
Exercise of stock options, shares         1,000       1,034
Vesting of restricted stock        
Vesting of restricted stock, shares         2,000        
Issuance of common stock, net of issuance costs of $250         (192) (192)
Issuance of common stock, net of issuance costs, shares         121,000        
Foreign currency translation adjustment         42 42
Net loss         (22,690) (22,690)
Ending balance, value at Dec. 31, 2022 $ 1 $ 111,443 $ (101,503) $ (32) $ 9,909
Ending balance, shares at Dec. 31, 2022 5,922,000